Menu
Dear Colleagues: Welcome to the September 2021 edition of NP+PA Perspectives in Dermatology, the ongoing quarterly supplement series to The Journal of Clinical and Aesthetic Dermatology. We have a diverse selection of content in this issue, which we hope you find applicable to your practice. First, we present a review article by Datta et al
Francesca Wolfe, MPAS, PA-C, is a physician assistant at Pennsylvania Dermatology Group and clinical instructor at Thomas Jefferson University Physician Assistant program in Philadelphia, Pennsylvania. Dear Colleagues: It brings me much joy to say these words—Welcome to the end of 2020! Welcome also to 2020’s final installment of NP+PA Perspectives in Dermatology, a quarterly supplement
Vol. 13, No. 7 • July 2020 Dear Colleagues: Welcome to the July 2020 issue of The Journal of Clinical and Aesthetic Dermatology. We begin the issue with an original research article by Fonseka et al, in which the authors examine the effects of ethinylestradiol (35ug)/cyproterone acetate (2mg) (EE/CPA) and ethinylestradiol (20ug)/desogestrel (0.15mg) (EE/DES), alone
Vol. 13, No. 6 • June 2020 Dear Colleagues: Welcome to the June 2020 issue of The Journal of Clinical and Aesthetic Dermatology. We begin this issue with original research from Mercieca et al, titled, “The Antibiotic Susceptibility Profile of Cutibacterium Acnes in Maltese Patients with Acne.” Here, the authors investigated the susceptibility profile of
Vol. 13, No. 5 • May 2020 Dear Colleagues: Welcome to the May 2020 issue of The Journal of Clinical and Aesthetic Dermatology. We begin the issue with a retrospective analysis from Patel et al, in which the authors investigated the efficacy of fixed-combination calcipotriene 0.005% plus betamethasone dipropionate 0.064% (Cal/BD) foam for the treatment
